Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Zhipeng Yan"'
Publikováno v:
Medicina Clínica. 158:596-602
Background There is no a unified opinion in the treatment of IgA nephropathy. This prospective cohort study was to explore the effectiveness and safety of tacrolimus for treatment of IgA (Immunoglobulin A) nephropathy patients. Methods In this study,
Autor:
Guanhua Lou, Chengyi Peng, Qingxia Gan, Hongrong Yan, Zhipeng Yan, Ju Hu, Qinwan Huang, Haijun Xiong
Publikováno v:
Revista Brasileira de Farmacognosia. 31:24-31
Coptis chinensis Franch., Ranunculaceae, is a widely used herbal medicine in Asian countries. It exhibits many important pharmacological effects. The rhizome is used as the crude drug for this medicinal plant. The objective of this study was to deter
Publikováno v:
Aging (Albany NY)
N6-methyladenosine (m6A) RNA methylation, involved in cancer initiation and progression, is dynamically regulated by the m6A RNA methylation regulators. However, the expression of m6A RNA methylation regulators in ovarian cancer and their correlation
Publikováno v:
International Ophthalmology. 40:269-279
Diabetic retinopathy (DR) especially proliferative diabetic retinopathy (PDR) is a serious eye disease. We aimed to identify key pathway and hub genes associated with PDR by analyzing the expression of retinal fibrovascular tissue in PDR patients. Fi
Autor:
Zhipeng Yan, Haotian Chen, Ying Lin, Zhengwei Zhou, Han Lei, Lili Fan, Tianxiang Zhang, Gang Yin, Guang Shu
Publikováno v:
Frontiers in Molecular Biosciences
Frontiers in Molecular Biosciences, Vol 8 (2021)
Frontiers in Molecular Biosciences, Vol 8 (2021)
Background: Checkpoint block-mediated tumor immunotherapy has obtained huge success in treating various malignancies. However, the efficacy of immunotherapies against ovarian cancer (OC) was low largely due to limited information on the tumor immune
Autor:
Zhipeng Yan, Yao Shen
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
To study the drug resistance problem caused by transporters, we leveraged multiple large-scale public data sets of drug sensitivity, cell line genetic and transcriptional profiles, and gene silencing experiments. Through systematic integration of the
Autor:
Lu Gao, Qingyuan Zhu, Xiangyu Yao, Yaling Zhang, Zhipeng Yan, Xiaoyu Pan, Li Wang, Junjun Cheng, Daitze Wu, Haixia Liu
Publikováno v:
Antiviral Research
The newly emerged severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) coronavirus initiated a pneumonia outbreak (COVID-19) that rapidly spread worldwide and quickly became a public health emergency of international concern; However to date,
Autor:
Zhipeng Yan, Gaosi Xu
Publikováno v:
Frontiers in Medicine
Frontiers in Medicine, Vol 7 (2020)
Frontiers in Medicine, Vol 7 (2020)
Anemia is a complication of chronic kidney disease (CKD), primarily due to insufficient secretion of erythropoietin (EPO) by the kidney. Erythropoiesis-stimulating agents (ESAs) are used to treat anemia associated with chronic kidney disease. A poor
Publikováno v:
SSRN Electronic Journal.
N6-methyladenosine (m6A) RNA methylation, involved in cancer initiation and progression, is dynamically regulated by the m6A RNA methylation regulators, including ‘writers’, ‘erasers’ and ‘readers’. However, the expression of m6A RNA meth
Autor:
Lili Xu, Man Wang, Mengru Wu, Jinwei Zhou, Yuping Shen, Huan Yang, Yangyang Zhang, Zhipeng Yan, Xia Guohua
Publikováno v:
Enzyme and Microbial Technology. 142:109690
Prosaikogenin D, a rare secondary saponin in Radix Bupleuri, has much higher in vivo bioactivities than its original glycoside saikosaponin B2. Its preparation methods, such as conventional acid hydrolysis and column chromatograph, are unfriendly to